{"id":"https://openalex.org/W2743584451","doi":null,"title":"HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.","display_name":"HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2743584451","mag":"2743584451","pmid":"https://pubmed.ncbi.nlm.nih.gov/28402930","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5677040"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:4648207","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5677040","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W2743584451"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5677040","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079551705","display_name":"Paul A. Volberding","orcid":"https://orcid.org/0000-0002-9608-192X","observed_orcids":["https://orcid.org/0000-0002-9608-192X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul A Volberding","raw_affiliation_strings":["University of California San Francisco-Gladstone Center for AIDS Research, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco-Gladstone Center for AIDS Research, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5079551705"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":3.2041,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.91683778,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"25","issue":"1","first_page":"17","last_page":"24"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.33329999446868896,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-antiretroviral-therapy","display_name":"HIV antiretroviral therapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.878000020980835},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-initiation","display_name":"treatment initiation","score":0.6019999980926514},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.8659999966621399},{"id":"https://openalex.org/keywords/antiretroviral-therapy-switching","display_name":"antiretroviral therapy switching","score":0.8550000190734863},{"id":"https://openalex.org/keywords/laboratory-monitoring","display_name":"laboratory monitoring","score":0.9829999804496765},{"id":"https://openalex.org/keywords/engagement-in-care","display_name":"engagement in care","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antiretroviral-therapy-adherence","display_name":"antiretroviral therapy adherence","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8455229997634888},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.8433089256286621},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5696331262588501},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5476086735725403},{"id":"https://openalex.org/C3019165603","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral treatment","level":5,"score":0.49303409457206726},{"id":"https://openalex.org/C2909254382","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"ANTIRETROVIRAL AGENTS","level":5,"score":0.4588426351547241},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.44686219096183777},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.37049227952957153},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2322596311569214}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012958","descriptor_name":"Societies, Scientific","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmh:oai:europepmc.org:4648207","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5677040","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:28402930","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28402930","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Topics in antiviral medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5677040","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5677040/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Top Antivir Med","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt9tk0j2c1","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/9tk0j2c1","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Topics in antiviral medicine, vol 25, iss 1","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4648207","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5677040","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000898549","display_name":"UCSF-Bay Area Center for AIDS Research","funder_award_id":"P30AI027763","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1898465070","https://openalex.org/W1988077091","https://openalex.org/W2035445723","https://openalex.org/W2108848278","https://openalex.org/W2148750104","https://openalex.org/W2148958761","https://openalex.org/W2467247336","https://openalex.org/W4302369756"],"related_works":["https://openalex.org/W4404891514","https://openalex.org/W2411789879","https://openalex.org/W2938344540","https://openalex.org/W2509194649","https://openalex.org/W2915372808","https://openalex.org/W2182777591","https://openalex.org/W2122280827","https://openalex.org/W4256717774","https://openalex.org/W4240243247","https://openalex.org/W4310567938"],"abstract_inverted_index":{"Updated":[0],"recommendations":[1,36],"from":[2],"the":[3,12,24,27],"IAS-USA":[4,117],"Antiretroviral":[5],"Guidelines":[6],"Panel":[7],"on":[8],"antiretroviral":[9,41,45,73,83,92,97],"therapy":[10,74,98],"for":[11,56],"treatment":[13,68],"and":[14,66,75,79,94],"prevention":[15,101],"of":[16,26,96],"HIV":[17,100,111],"infection":[18],"in":[19,23,31,58,88,110,127],"adults":[20],"were":[21],"published":[22],"Journal":[25],"American":[28],"Medical":[29],"Association":[30],"2016.":[32,129],"The":[33,70],"updated,":[34],"evidence-based":[35],"address":[37],"when":[38,78],"to":[39,81,91],"initiate":[40],"therapy,":[42,84,93],"recommended":[43,54],"initial":[44],"regimens,":[46,53],"including":[47],"integrase":[48],"strand":[49],"transfer":[50],"inhibitor":[51],"(InSTI)-based":[52],"regimens":[55],"persons":[57],"whom":[59],"an":[60,64,116],"InSTI":[61],"is":[62],"not":[63],"option,":[65],"special":[67],"considerations.":[69],"interface":[71],"between":[72],"opportunistic":[76],"infections,":[77],"how":[80],"switch":[82],"laboratory":[85],"monitoring,":[86],"engagement":[87],"care,":[89],"adherence":[90],"use":[95],"as":[99,105,107],"are":[102],"also":[103],"discussed,":[104],"well":[106],"future":[108],"directions":[109],"treatment.":[112],"This":[113],"article":[114],"summarizes":[115],"continuing":[118],"education":[119],"webinar":[120],"presented":[121],"by":[122],"Paul":[123],"A.":[124],"Volberding,":[125],"MD,":[126],"August":[128]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2743584451","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-08-17T00:00:00"}
